Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
GLP-1 receptor agonists have transformed diabetes care, but the long-term safety of GLP-1 therapies has become an important topic as treatment continues for many years. Initially, clinicians prescribed these medications primarily for glycemic control in patients with type 2 diabetes. However, their role has expanded due to additional benefits in …
Read More »GLP-1s and Gastrointestinal Safety in Long-Term Use: What Happens After Year Three?
